Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)

Abroad (travel likely)RecruitingPHASE2

Conditions

Salivary Gland Cancer · Thyroid Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National University Cancer Institute Singapore, Singapore, Singapore
Contact: Study coordinator (Boon Cher Prof Goh, MD) · phcgbc@nus.edu.sg · +65 6908 2222
Contact: Study coordinator (Wan Qin Dr Chong, MD) · wan_qin_chong@nuhs.edu.sg · +65 6908 2222
Contact: Principal Investigator (Wan Qin Dr Chong, MD)

Study leads

Wan Qin Dr Chong, MD
Principal Investigator
National University Hospital, Singapore

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

DESTINY-PANTUMOUR04

Adenocarcinoma (NOS) · Anal Cancer · Bladder Cancer

Abroad (travel likely)Recruiting

Birmingham, United States · Bullhead City, United States

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Breast Cancer · Gastric Cancer · Esophageal Cancer

Abroad (travel likely)RecruitingPHASE2

Prescott, United States · Littleton, United States

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

Metastatic Salivary Gland Carcinoma · Recurrent Salivary Gland Carcinoma · Stage III Major Salivary Gland Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Duarte, United States

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

Salivary Gland Cancer · HER2 Gene Mutation

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States · Chicago, United States